Thursday, November 12, 2026

currencies

3 articles

Dollar Index Drops 10.8% as Global Currency Markets Realign

Dollar Index Drops 10.8% as Global Currency Markets Realign

The U.S. Dollar Index fell 10.8% in early 2026, continuing a shift that saw the euro rise 14% in 2025. The British pound gained 7% in 2025 but dropped to €1.13 by November 2026, its weakest level against the euro since April 2023.

LM Salvado•
Dollar Rebounds From 2022 Lows as Pound Hits $1.3086 on UK Budget Fears

Dollar Rebounds From 2022 Lows as Pound Hits $1.3086 on UK Budget Fears

The dollar recovered from its lowest level since 2022 as the British pound fell to $1.3086 ahead of Chancellor Rachel Reeves' November 26 budget. UK 30-year gilt yields reached 5.21%, the highest since 1998, while global currency markets face uncertainty from Fed leadership transition and geopolitical tensions.

ViaNews Editorial Team•
Dollar Hits 2022 Low as Euro Surges 14%, Reshaping $6.6 Trillion Daily FX Market

Dollar Hits 2022 Low as Euro Surges 14%, Reshaping $6.6 Trillion Daily FX Market

The US dollar fell to its lowest level since 2022, with the euro gaining 14% in 2025 and the British pound up 7%. The currency shift affects $6.6 trillion in daily foreign exchange transactions as central banks from Frankfurt to London navigate diverging monetary pressures ahead of a Federal Reserve leadership transition in June 2026.

ViaNews Editorial Team•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,565 source documents archived
Query this data → isubstrate.com